CervoMed prices unregistered $10.5 million private placement at $3.14 per unit
PUBT · 6d ago
Share
Listen to the news
- CervoMed priced an unregistered private placement expected to raise about USD 10.5 million in upfront gross proceeds.
- Deal sells 3,360,377 units at USD 3.14 per common-share unit, or USD 3.139 per pre-funded-warrant unit.
- Each unit includes common stock or a pre-funded warrant, one Series B warrant, one Series C warrant.
- Warrants could add up to about USD 21.7 million if fully exercised for cash; Series B strike USD 3.32, Series C strike USD 3.14.
- Proceeds extend cash runway into Q2 2027; funding supports partnering to advance neflamapimod into Phase 3 in dementia with Lewy bodies.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cervomed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606100730PRIMZONEFULLFEED9734701) on June 10, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved